Castle Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35
Closed -$16K 264
2022
Q3
$16K Hold
35
0.01% 357
2022
Q2
$17K Buy
+35
New +$17.3K 0.01% 335

Other funds holding ELV

Castle Wealth Management's ELV Position: Q4 2022 in Review

Castle Wealth Management sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 35 shares — an estimated $16K sold.

Castle Wealth Management first reported a position in ELV in Q2 2022 and held it in 2 quarters. The position peaked at $17K in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Castle Wealth Management reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Castle Wealth Management sold 35 Elevance Health shares in Q4 2022, an estimated $16K.
  • Castle Wealth Management first reported a position in Elevance Health in Q2 2022 and held it in 2 quarters.
  • Castle Wealth Management's Elevance Health position peaked at $17K in Q2 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.